Internal Medicine, Infectious Disease · Iowa City, IA
NPI
1730161050
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
200 Hawkins Dr
Iowa City, IA, 52242
Phone (319) 356-8969
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
192 services
Medicare patients, 2024
108
Average age 71
Drug cost, 2024
$1.1M
919 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason H Barker was code 99232 (hospital e&m - subsequent), 56 times for 34 patients. In total Jason H Barker billed 192 services in 16 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 56 | 34 | $56.62 | $3,171 |
| 99214 Office E&M - Established | Facility | 36 | 27 | $58.43 | $2,103 |
| 99222 Hospital E&M - Initial | Facility | 28 | 28 | $93.44 | $2,616 |
| 99223 Hospital E&M - Initial | Facility | 23 | 23 | $113.16 | $2,603 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 11 | $85.39 | $1,622 |
By year: 2022 $15K for 170 services; 2023 $15K for 187 services; 2024 $13K for 192 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jason H Barker prescribed most often to Medicare patients was Atorvastatin Calcium, with 80 prescriptions and refills. In total Jason H Barker wrote 919 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 80 | 98 | Under 11 | $217 |
| Descovy Emtricitabine/Tenofov Alafenam | 59 | 59 | Under 11 | $131K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 49 | 49 | Under 11 | $177K |
| Amlodipine Besylate Generic | 44 | 44 | Under 11 | $79.71 |
| Dovato Dolutegravir Sodium/Lamivudine | 42 | 42 | Under 11 | $126K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 39 | 45 | Under 11 | $172K |
| Tivicay Dolutegravir Sodium | 38 | 38 | Under 11 | $91K |
| Metformin Hcl Er Metformin Hcl | 37 | 37 | Under 11 | $63.12 |
| Delstrigo Doravirine/Lamivu/Tenofov Diso | 35 | 35 | Under 11 | $90K |
| Etravirine Generic | 27 | 27 | Under 11 | $32K |
| Prezcobix Darunavir/Cobicistat | 24 | 24 | Under 11 | $60K |
| Lamivudine Generic | 23 | 23 | Under 11 | $1,167 |
| Omeprazole Generic | 17 | 17 | Under 11 | $126 |
| Ritonavir Generic | 17 | 21 | Under 11 | $2,724 |
| Acyclovir Generic | 17 | 17 | Under 11 | $77.06 |
Brand drugs: 386 claims; generic drugs: 533 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jason H Barker were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.